These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8837597)

  • 1. Can a killer be arrested?
    Kierszenbaum F
    Nat Med; 1996 Oct; 2(10):1071-2. PubMed ID: 8837597
    [No Abstract]   [Full Text] [Related]  

  • 2. Chagas disease 101.
    Clayton J
    Nature; 2010 Jun; 465(7301):S4-5. PubMed ID: 20571553
    [No Abstract]   [Full Text] [Related]  

  • 3. Chagas disease: pushing through the pipeline.
    Clayton J
    Nature; 2010 Jun; 465(7301):S12-5. PubMed ID: 20571548
    [No Abstract]   [Full Text] [Related]  

  • 4. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.
    Urbina JA; McKerrow JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7923-4. PubMed ID: 26578701
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
    Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7925. PubMed ID: 26578702
    [No Abstract]   [Full Text] [Related]  

  • 7. Research for new antichagasic drugs.
    Mester B; Claramunt RM; Elguero J; Atienza J; Gómez Barrio A; Escario JA
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1990-3. PubMed ID: 1797419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasitological cure of Chagas disease: is it possible? Is it relevant?
    Urbina JA
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754
    [No Abstract]   [Full Text] [Related]  

  • 9. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi.
    Brand S; Ko EJ; Viayna E; Thompson S; Spinks D; Thomas M; Sandberg L; Francisco AF; Jayawardhana S; Smith VC; Jansen C; De Rycker M; Thomas J; MacLean L; Osuna-Cabello M; Riley J; Scullion P; Stojanovski L; Simeons FRC; Epemolu O; Shishikura Y; Crouch SD; Bakshi TS; Nixon CJ; Reid IH; Hill AP; Underwood TZ; Hindley SJ; Robinson SA; Kelly JM; Fiandor JM; Wyatt PG; Marco M; Miles TJ; Read KD; Gilbert IH
    J Med Chem; 2017 Sep; 60(17):7284-7299. PubMed ID: 28844141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.
    Molina J; Brener Z; Romanha AJ; Urbina JA
    J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
    Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
    J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
    Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

  • 14. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.
    Grosso NL; Bua J; Perrone AE; Gonzalez MN; Bustos PL; Postan M; Fichera LE
    Exp Parasitol; 2010 Oct; 126(2):239-44. PubMed ID: 20493848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific chemotherapy of Chagas disease: controversies and advances.
    Urbina JA; Docampo R
    Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of Trypanosoma cruzi infections.
    Brener Z
    Adv Pharmacol Chemother; 1975; 13():1-81. PubMed ID: 812348
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi.
    Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG
    Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
    Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
    Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.